Gene · 2617
Papers1,667
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,667
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Shared mechanisms and pathological phenotypes underlying aminoacyl-tRNA synthetase-related neuropathies. | Neural Regen Res | 2026 | 39851138 | PubTator, text mining | PubMed |
| CT Radiomics Combined with Metabolic-Biomarkers Enables Early Recurrence Prediction in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2025 | 41049156 | PubTator, text mining | PubMed |
| Molecular determinants of cesium- and glycine-dependent glycine receptor activation. | Sci Rep | 2025 | 40987909 | PubTator, text mining | PubMed |
| The medical student stressor questionnaire (MSSQ): validation and reliability in Turkish students. | BMC Med Educ | 2025 | 40753444 | PubTator, text mining | PubMed |
A GWAS Meta-meta-analysis and In-depth Silico Pharmacogenomic Investigations in Identification of APOE and Other Genes Associated with Pain, Anti-inflammatory, and Immunomodulating Agents in Opioid Use Disorder (OUD) Derived from 14.91 M Subjects. | Cell Mol Neurobiol | 2025 | 40742457 | PubTator, text mining | PubMed |
| Binding patterns of glycine receptor autoantibodies are related to clinical syndromes. | Acta Neuropathol Commun | 2025 | 40739585 | PubTator, text mining | PubMed |
| Serum zonulin level in autistic children and its relation to severity of symptoms a case-control study. | Sci Rep | 2025 | 40738920 | PubTator, text mining | PubMed |
| KLF16-induced Increase of GARS Promotes Glycolysis in Hepatocellular Carcinoma by Stabilizing FOXK1. | Tohoku J Exp Med | 2025 | 40603105 | PubTator, text mining | PubMed |
| Crystal structures of Mycobacterium tuberculosis and Mycobacterium thermoresistibile glycyl-tRNA synthetases in various liganded states. | PLoS One | 2025 | 40587479 | PubTator, text mining | PubMed |
| Editorial to the Special Issue "Glycine-(and D-Serine)-Related Neurotransmission: Promising Therapeutic Targets with Still Unsolved Problems". | Biomedicines | 2025 | 40426967 | PubTator, text mining | PubMed |
| Utilization of a precision medicine genetic and psychosocial approach in outcome assessment of bariatric weight loss surgery: a narrative review. | Front Public Health | 2025 | 40376058 | PubTator, text mining | PubMed |
| Analysis of the mechanism of skeletal muscle atrophy from the pathway of decreased protein synthesis. | Front Physiol | 2025 | 40352150 | PubTator, text mining | PubMed |
| Milestone Review: Unlocking the Proteomics of Glycine Receptor Complexes. | J Neurochem | 2025 | 40285371 | PubTator, text mining | PubMed |
| Glycine receptor activation promotes pancreatic islet cell proliferation via the PI3K/mTORC1/p70S6K pathway. | JCI Insight | 2025 | 40260914 | PubTator, text mining | PubMed |
| Molecular correlates of glycine receptor activity in human β cells. | Mol Metab | 2025 | 40258441 | PubTator, text mining | PubMed |
| Glycyl-tRNA Synthetase as a Target for Antiviral Drug Screening Against Influenza Virus. | Int J Mol Sci | 2025 | 40243525 | PubTator, text mining | PubMed |
| Glycyl-tRNA sequestration is a unifying mechanism underlying GARS1-associated peripheral neuropathy. | Nucleic Acids Res | 2025 | 40119731 | PubTator, text mining | PubMed |
| Allosteric modulation and direct activation of glycine receptors by a tricyclic sulfonamide. | Sci Rep | 2025 | 39953280 | PubTator, text mining | PubMed |
| Antisynthetase syndrome with anti-glycyl tRNA synthetase antibodies in a patient with axial spondyloarthritis treated with tumor necrosis factor-α inhibitors. | Reumatismo | 2025 | 39932245 | PubTator, text mining | PubMed |
| Impaired Presynaptic Function Contributes Significantly to the Pathology of Glycine Receptor Autoantibodies. | Neurol Neuroimmunol Neuroinflamm | 2025 | 39819053 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2617/papers?page=2